AED Antiepileptic drugs
AIDS Autoimmune deficiency syndrome
ALO Actinomycoses-like organism
AMH Australian Medicines Handbook
ART Anti-retroviral therapy
ASCEPT Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists 
BBT Basal body temperature
bd Twice daily
BMD Bone mineral density
BMI Body mass index
BP Blood pressure
BRCA Breast cancer
BTB Break-through bleeding
CEU Clinical Effectiveness Unit
CHC Combined hormonal contraception
CHD Coronary heart disease
CMV  Cytomegalovirus
COC Combined oral contraceptive
COCP Combined oral contraceptive pill
CPA Cyproterone acetate
CT Computerised tomography
Cu-IUD Copper intrauterine device
CVD Cardiovascular disease
CVR Combined vaginal ring
D&C Dilatation and curettage
DMPA Depot medroxyprogesterone acetate
DVT Deep vein thrombosis
E2 Oestradiol
EC Emergency contraception
ECP Emergency contraceptive pills
EE Ethinyl oestradiol
ENG Etonogestrel
FABMs Fertility awareness based methods
FH Family History
FPNSW Family Planning New South Wales
FPOs  Family Planning Organisations
FPQ Family Planning Queensland
FPT Family Planning Tasmania
FPV Family Planning Victoria
FPWA FPWA Sexual Health Services
FPWNT Family Planning Welfare Association of NT
FSH Follicle stimulating hormone
FSRH Faculty of Sexual and Reproductive Healthcare (UK)
GA General anaesthetic
hCG Human chorionic gonadotrophins
HDL High density lipoproteins
HIV Human immunodeficiency virus
HMB Heavy menstrual bleeding
HPV Human papilloma virus
HRT Hormone replacement therapy
HSIL High grade squamous intraepithelial lesions
ICSI Intracytaplasmic sperm injection
IHD Ischaemic heart disease
IM Intramuscular
IPPF International Planned Parenthood Federation
IUD (IUCD)  Intra uterine (contraceptive) device
IVDU Intravenous drug user
LA Local anaesthetic
LAM Lactational amenorrhoea
LARC Long acting reversible contraceptive
LFT Liver function tests
LGEA Low grade epithelial abnormality
LH Luteinising hormone
LNG Levonorgestrel
LNG-EC Levonorgestrel Emergency Contraception
LNG-IUD Levonogestrel intrauterine device
LNMP Last normal menstrual period
LSC Lichen simplex chronicus
LSIL Low grade squamous intraepithelial lesion
mcg Micrograms
MEC Medical eligibility criteria
mgm Milligrams
MI Myocardial infarction
MRI Magnetic Resonance Imaging
MSU Midstream urine
NE Norethisterone
NGU Non-gonococcal urethritis
NPS RADAR National Prescribing Service Ltd rational assessment of drugs and research
NTD Neural tube defect
OTC Over the counter
PBS Pharmaceutical benefits scheme
PCR Polymerase chain reaction
PE Pulmonary embolism
PH Past history
PI Product Information
PID Pelvic inflammatory disease
PMDD Premenstrual dysphoric disorder
PMS Premenstrual syndrome
po Per os (by mouth)
PO Progestogen only
POC Progestogen only contraceptive
POP Progestogen only pill
PSA Pharmaceutical Society of Australia
PVD Peripheral vascular disease
RACGP Royal Australian College of General Practitioners
RCOG Royal College of Obstetricians and Gynaecologists (UK)
RCT Randomised controlled trial
RNA Ribonucleic acid
SBE Subacute bacterial endocarditis
SERM Selective oestrogen receptor modulator
SH&FPA Sexual Health and Family Planning Association
SH&FPACT Sexual Health & Family Planning ACT
SHBG Sex hormone binding globulin
SLE Systemic lupus erythematosis
STIs Sexually transmissible infections
TDEC Therapeutic Devices Evaluation Committee
TGA Therapeutic Goods Administration
TIA Transient ischaemic attack
UKMEC UK Medical Eligibility Criteria
UPA Ulipristal acetate
UPSI Unprotected sexual intercourse
UTI Urinary tract infection
VTE Venous thromboembolic event
WHO World Health Organisation
WHO MEC WHO Medical Eligibility Criteria

site created by Longueville Media